Navigation Links
Focused Treatment For Childhood Cancer

A poorly understood type of childhood brain cancer has a unique molecule signature that may point to which therapies could best fight it.// Armed with targeted molecular treatments, doctors may be able to fight the disease without risking the side effects of prolonged and powerful radiation and chemotherapy at an early age.

The latest research is a collaborative effort looking at a type of childhood tumour known as medulloblastoma, the most common childhood tumour of the CNS. The cancer usually strikes between the ages of 5 and 10. Medulloblastomas are highly malignant, and can spread to the spine and other parts of the body. But over the past few decades, refined treatments have increased survival rates until approximately 80 percent of children survive for five to 10 years after diagnosis.

But the therapies aren't perfect. Radiation and chemotherapy for up to a year at such a young age can lead to hearing loss, cataracts and severe learning disabilities that can leave children unable to live independently in later life.

Led by Dr. Scott Pomeroy, an associate professor of neurology at Children's Hospital in Boston, the researchers found that increased activity of Sonic Hedgehog (SHH), a signaling molecule crucial to brain development, is linked to one type of medulloblastoma. "As compared to chemotherapy, which is non-specific and damages all cells … these very focused treatments will only work on those tumors that have that particular molecular pathway active," says Pomeroy.

Recently developed compounds that can block the uncontrolled SHH signaling found in the tumors could potentially be used as a therapy in children with medulloblastoma. Researchers also found that the clinical outcome of an individual child's struggle with medulloblastoma could be accurately predicted by examining the patterns of gene expression in the cancer at the time of diagnosis.
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Inadequate Drug Treatment For Youth
9. FDA Approves New surgery Treatment for Farsightedness
10. Treatment of antibiotics ineffectual in bronchitis
11. Oxygen Treatment may be injurious
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... LYNDHURST, N.J. (PRWEB) , ... September 17, 2019 ... ... in a wide array of services, welcomes Dr. Yevgeniya (Jenny) Gartshteyn to their ... University Medical Center, where she previously held the Clinical Appointment of Assistant Professor ...
(Date:9/14/2019)... ... September 13, 2019 , ... ... detection and treatment of infectious diseases at its annual Congress (WMIC) recently ... detection of residual HIV infected cell persistence and the development of pathogen-specific ...
(Date:9/12/2019)... Ohio (PRWEB) , ... September 12, 2019 , ... ... on both a local and national scale in two recent and well-renowned listing ... country’s fastest-growing privately held businesses for the 2019 year. , Dr. Jeffrey ...
(Date:9/11/2019)... ... 11, 2019 , ... Workplace injuries cost individuals, organisations and ... risks which lead to musculoskeletal disorders (MSDs). , Starting with the individual ... at Soter Analytics helps avoid ergonomic injury by coaching workers to ...
(Date:9/11/2019)... ... September 11, 2019 , ... ... accredited continuing medical education (CME) provider, is the official accreditor for PAINWeek, the ... vetted speakers, and screened topics, as it has done for the past ten ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... ... 13, 2019 , ... Corey Stern , a partner at Levy Konigsberg, ... Archibald over at least 3 decades while employed by Rockefeller University Hospital (“RUH”). ... Court - Southern District of New York, No. 1:19-cv-01403), the first case filed against ...
(Date:9/14/2019)... N.J. (PRWEB) , ... September 14, 2019 , ... ... trial of four plaintiffs living with peritoneal mesothelioma, a jury in Middlesex County ... first consolidated trial of plaintiffs alleging their mesotheliomas were caused by asbestos-containing J&J ...
(Date:9/11/2019)... China (PRWEB) , ... September ... ... Co., Ltd.“Jiuzhou Pharmaceutical, a world leading Active Pharmaceutical Ingredients (API) contract development ... commitment for the purchase of Suzhou Novartis Pharmaceutical Technology Ltd (SNPT), an ...
Breaking Medicine Technology: